首页> 外国专利> Anti-adrenomedulin antibody (ADM) or anti-ADM antibody fragment or protein scaffold without anti-ADM Ig to reduce the risk of mortality in a patient suffering from a chronic or acute disease or an acute condition

Anti-adrenomedulin antibody (ADM) or anti-ADM antibody fragment or protein scaffold without anti-ADM Ig to reduce the risk of mortality in a patient suffering from a chronic or acute disease or an acute condition

机译:不含抗ADM Ig的抗肾上腺髓质蛋白抗体(ADM)或抗ADM抗体片段或蛋白支架可降低患有慢性或急性疾病或急性疾病的患者的死亡风险

摘要

Anti-adrenomedulin antibody (ADM) or a fragment of anti-adrenomedulin antibody or a protein scaffold without anti-ADM Ig for use in the treatment or prevention of SIRS, meningitis, septicemia, shock, for example septic shock in a patient for reduction of the risk of mortality for said patient in which said antibody or fragment binds to the N-terminal part, amino acids 1-21, of adrenomedulin: YRQSMNNFQGLRSFGCRFGTC; SEC. ID. nº 23.
机译:抗肾上腺髓质素抗体(ADM)或抗肾上腺髓质素抗体的片段或不含抗ADM Ig的蛋白支架,用于治疗或预防SIRS,脑膜炎,败血病,休克,例如患者的败血性休克,以减轻或减轻对于其中所述抗体或片段结合到肾上腺髓质素:YRQSMNNFQGLRSFGCRFGTC的N末端部分1-21位氨基酸的患者的死亡风险; SEC。 ID。第23。

著录项

  • 公开/公告号ES2494190T3

    专利类型

  • 公开/公告日2014-09-15

    原文格式PDF

  • 申请/专利权人 ADRENOMED AG;

    申请/专利号ES20120193118T

  • 发明设计人 BERGMANN ANDREAS;

    申请日2012-11-16

  • 分类号C07K16/26;A61K39/395;A61P9;A61P13/12;A61P31;

  • 国家 ES

  • 入库时间 2022-08-21 15:55:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号